Interventional Cardiology Devices And Equipment Market Report 2026

Interventional Cardiology Devices And Equipment Market Overview

• Interventional Cardiology Devices And Equipment market size has reached to $15.65 billion in 2025 • Expected to grow to $21.76 billion in 2030 at a compound annual growth rate (CAGR) of 7.2% • Growth Driver: Rising Prevalence Of Cardiovascular Diseases Driving Market Growth Due To Increased Demand For Interventional Cardiology Procedures • Market Trend: Innovative Opn Nc Technology Sets The Standard In Interventional Cardiology • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Interventional Cardiology Devices And Equipment Market?

Interventional cardiology devices are specialized medical instruments designed for minimally invasive heart procedures. These include tools such as stents, catheters, and guidewires, used to treat heart conditions through techniques such as angioplasty and stent placement. The main types of interventional cardiology devices and equipment are angioplasty balloons, angioplasty stents, catheters, plaque modification devices, and other interventional cardiology devices. The catheter is a tubular medical device for insertion into canals, vessels, passageways, or body cavities to permit injection or withdrawal of fluids or for keeping the passage open. The market is divided by age group into new-born (0-30 days), infant (31 days-1 year), children (1-18 years), and adult (18+ years). The various applications involved are hospitals, clinics, cardiac catheterization labs, and ambulatory surgical centres.

What Is The Interventional Cardiology Devices And Equipment Market Growth Forecast?

The interventional cardiology devices and equipment market size is expected to see strong growth in the next few years. It will grow to $21.76 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to increasing demand for next-generation interventional devices, rising adoption of AI-assisted cardiac procedures, expansion of outpatient and ambulatory cardiac care, growing focus on patient-specific therapies, increasing investments in cardiovascular innovation. Major trends in the forecast period include increasing adoption of drug-eluting and bioabsorbable stents, rising use of advanced catheter-based therapies, growing integration of imaging-guided interventions, expansion of minimally invasive cardiac procedures, enhanced focus on precision and patient safety.

Global Interventional Cardiology Devices And Equipment Market Segmentation

1) By Type: Angioplasty Balloons, Angioplasty Stents, Catheters, Plaque Modification Devices, Other Interventional Cardiology Devices 2) By Age Group: New-born (0-30 days), Infant (31 days-1 year), Children (1-18 years), Adult (18+ years) 3) By Application: Hospitals, Clinics, Cardiac Catheterization Labs, Ambulatory Surgical Centers Subsegments: 1) By Angioplasty Balloons: Normal Balloons, Drug-Eluting Balloons, Cutting Balloons 2) By Angioplasty Stents: Bare-Metal Stents (BMS), Drug-Eluting Stents (DES), Bioabsorbable Stents 3) By Catheters: Guiding Catheters, Balloon Catheters, Angiography Catheters 4) By Plaque Modification Devices: Atherectomy Devices, Thrombectomy Devices 5) By Other Interventional Cardiology Devices: Guidewires, Vascular Closure Devices, Inflation Devices

What Is The Driver Of The Interventional Cardiology Devices And Equipment Market?

Increase in cardiovascular diseases is expected to propel the growth of interventional cardiology devices and equipment market. Cardiovascular diseases are health problems that are associated with the blood vessels, circulatory system as well as heart. Cardiovascular diseases are on the rise due to poor diets, lack of physical activity, stress, smoking, and obesity. The increasing incidence of cardiovascular diseases is fueling the demand for interventional cardiology devices, as more heart patients require advanced tools for minimally invasive treatments, leading to market growth. For instance, in October 2025, according to the Australian Institute of Health and Welfare, an Australia-based government agency, cardiovascular disease accounted for almost 12 percent of the total burden of disease in Australia in 2024 with 14 percent for males and 10 percent for females, and Australians lost an estimated 685,000 years of healthy life equivalent to 25.5 per 1,000 population due to all forms of cardiovascular disease. Therefore, the increase in cardiovascular diseases is going to propel the growth of interventional cardiology devices and equipment industry going forward.

Key Players In The Global Interventional Cardiology Devices And Equipment Market

Major companies operating in the interventional cardiology devices and equipment market are GE Healthcare, Abbott Laboratories, Boston Scientific Corporation, Medtronic Inc., Johnson & Johnson, B. Braun Melsungen AG, Biosensors International Ltd, Cook Medical LLC, Biotronik SE & Co. KG, ACIST Medical Systems Inc., Cordis Corporation, Terumo Corporation, Cardinal Health Inc., iVascular GmbH, Teleflex Incorporated, Merit Medical Systems Inc., MicroPort Scientific Corporation, Asahi Intecc Co. Ltd., AngioDynamics, C. R. Bard Inc., Endologix Inc., Lombard Medical Limited, Spectranetics Corporation, Vascular Solutions Inc., W. L. Gore & Associates Inc., Cardiva Medical Inc., Cardiovascular Systems Inc., ClearStream Technologies Ltd., Contego Medical LLC, Shockwave Medical Inc.

Global Interventional Cardiology Devices And Equipment Market Trends and Insights

Major companies operating in the interventional cardiology devices and equipment market are focusing on innovative technological products such as, percutaneous transluminal coronary angioplasty (PTCA) to meet the growing demand for minimally invasive procedures in the treatment of cardiovascular diseases. The percutaneous transluminal coronary angioplasty (PTCA) dilatation catheter with Twin-Wall technology provides a superior solution for the treatment of challenging coronary lesions. For instance, in February 2023, SIS Medical AG, a Switzerland-based medical company, launched the OPN NC percutaneous transluminal coronary angioplasty (PTCA) dilatation catheter with Twin-Wall technology. It is a next-generation balloon catheter that is designed to provide superior performance in challenging coronary lesions. The OPN NC percutaneous transluminal coronary angioplasty (PTCA) catheter has the potential to improve the outcomes of patients with coronary artery disease.

What Are Latest Mergers And Acquisitions In The Interventional Cardiology Devices And Equipment Market?

In March 2025, Boston Scientific, a US-basedmedical device company, acquired SoniVie Ltd., for approximately $540 million. With this acquisition, Boston Scientific aims to enhance its interventional cardiology therapy offerings by integrating SoniVie's TIVUS Intravascular Ultrasound System, an investigational ultrasound-based renal denervation technology designed to treat hypertensive disorders. SoniVie is an Israel-based provider of investigational intravascular ultrasound systems focused on nerve ablation for renal denervation.

Regional Outlook

North America was the largest region in the global interventional cardiology devices and equipment market in 2025. Western Europe was the second-largest region in the interventional cardiology devices and equipment market. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

What Defines the Interventional Cardiology Devices And Equipment Market?

The interventional cardiology devices and equipment market consists of sales of equipment with technologies such as vascular closure, atherectomy, intravascular ultrasound, fractional flow reserve, and optical coherence tomography (OCT) that are used for the treatment of interventional structural heart diseases. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.